← FDA DRUG APPROVALS

FDA ANDA · ANDA040500

PROMETHAZINE HYDROCHLORIDE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA040500
TYPE
ANDA
ORIGINAL APPROVAL
2003-06-30
LATEST ACTION
2005-06-09
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Prescription

Products

PROMETHAZINE HYDROCHLORIDEPrescription
PROMETHAZINE HYDROCHLORIDE 12.5MG · SUPPOSITORY · RECTAL
PROMETHAZINE HYDROCHLORIDEPrescription
PROMETHAZINE HYDROCHLORIDE 25MG · SUPPOSITORY · RECTAL

Approval history

2005-06-09Labeling · Supplement 3AP
2003-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →